The Peter Attia Drive

Peter Attia

At a Glance

The Peter Attia Drive is hosted by Peter Attia covering GLP-1 Agonists, Sarcopenia, Myostatin Inhibitors, and FDA Approval. Notable guests include Dr. Ralph DeFronzo, and Brian Kennedy (Former CEO, Buck Institute). Episodes span from Mar 2025 to Jul 2025.

2 episodes45 total claims12 topics covered

2 episodes

357 ‒ A new era of longevity science: models of aging, rapamycin trials, biological clocks, & more

Jul 21, 2025

›

The longevity research field has matured significantly, with a major inflection in investor and philanthropic interest around 2017-2018, moving from a niche academic pursuit to a more robustly fund...

Neutral0 quotes0 findings

LongevityAging ResearchHealthspanmTOR Pathway+14 more

Pros & cons of GLP-1 weight loss drugs | Dr. Ralph DeFronzo

Mar 1, 2025

›

Current generation GLP-1 agonists are considered safe but cause significant weight loss that includes a concerning loss of muscle mass. Pharmaceutical companies are developing new drugs, such as my...

Neutral0 quotes0 findings

GLP-1 AgonistsSarcopeniaMyostatin InhibitorsFDA Approval+11 more

The Peter Attia Drive

At a Glance

2 episodes

Top Topics